General Information of the Compound
Compound ID
CP0179244
Compound Name
4-(pyridin-2-yl)-5-(quinolin-4-yl)thiazol-2-amine
    Show/Hide
Synonyms
4-(pyridin-2-yl)-5-(quinolin-4-yl)thiazol-2-amine
4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine
BDBM50151348
CHEMBL181640
SCHEMBL410002
UPYLCJSMNYCTLZ-UHFFFAOYSA-N
    Show/Hide
Structure
Formula
C17H12N4S
Molecular Weight
304.378
Canonical SMILES
Nc1nc(c(s1)-c1ccnc2ccccc12)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C17H12N4S/c18-17-21-15(14-7-3-4-9-19-14)16(22-17)12-8-10-20-13-6-2-1-5-11(12)13/h1-10H,(H2,18,21)
    Show/Hide
InChIKey
UPYLCJSMNYCTLZ-UHFFFAOYSA-N
Physicochemical Property
logP
4.0025
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
64.69
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9796486
SID: 14751893
ChEMBL ID
CHEMBL181640
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01221, TGF-beta receptor type-1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 274 nM
2 IC50 = 720 nM
Clinical Information about the Compound
Drug 1 ( 4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine )
Drug Name 4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine
Target(s)
TGF-beta receptor type I (TGFBR1)
Inhibitor